Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
100%(8 trials)

Phase Distribution

Ph phase_2
1
13%
Ph phase_3
5
63%
Ph phase_1
2
25%

Phase Distribution

2

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
5(62.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(8)

Detailed Status

Completed8

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (25.0%)
Phase 21 (12.5%)
Phase 35 (62.5%)

Trials by Status

completed8100%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_2

Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)

NCT00666679
completedphase_1

The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)

NCT00739297
completedphase_3

Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)

NCT00979901
completedphase_3

Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)

NCT00963599
completedphase_3

Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275)

NCT00090142
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT00666679Phase 2

Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)

Completed
NCT00739297Phase 1

The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)

Completed
NCT00979901Phase 3

Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)

Completed
NCT00963599Phase 3

Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)

Completed
NCT00090142Phase 3

Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275)

Completed
NCT00245570Phase 3

Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)

Completed
NCT00092131Phase 3

Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)

Completed
NCT01061333Phase 1

Early Airway Response to Allergen in Asthmatics (MK-0000-176)

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8